[{"abstract": "Judith Graves, a Florida woman, had sued the company, claiming that its osteoporosis drug, Fosamax, caused her jawbone to disintegrate.", "web_url": "https://www.nytimes.com/2010/11/20/business/20fosamax.html", "snippet": "Judith Graves, a Florida woman, had sued the company, claiming that its osteoporosis drug, Fosamax, caused her jawbone to disintegrate.", "lead_paragraph": "Merck on Friday won a signature jury trial against Judith Graves, a Florida woman who had sued the company and claimed that its osteoporosis drug, Fosamax, caused her jawbone to disintegrate.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2010/11/20/business/Fosamax/Fosamax-jumbo.jpg", "height": 1024, "width": 768, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}], "headline": {"main": "Merck Not at Fault in Fosamax Trial, Jurors Say", "kicker": null, "content_kicker": null, "print_headline": "In Trial on Bone Loss, Jurors Say Merck Is Not at Fault", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Fosamax (Drug)", "rank": 2, "major": "N"}], "pub_date": "2010-11-20T00:52:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/cdf626c4-2ba0-57e7-8eee-420b6e005988", "word_count": 483, "uri": "nyt://article/cdf626c4-2ba0-57e7-8eee-420b6e005988"}, {"abstract": "Patients with chronic kidney disease who took Vytorin, a cholesterol-lowering pill, had one-sixth fewer heart attacks, strokes or operations to unblock their arteries than patients taking a placebo.", "web_url": "https://www.nytimes.com/2010/11/21/health/research/21drug.html", "snippet": "Patients with chronic kidney disease who took Vytorin, a cholesterol-lowering pill, had one-sixth fewer heart attacks, strokes or operations to unblock their arteries than patients taking a placebo.", "lead_paragraph": "Patients with chronic kidney disease who took Vytorin, a cholesterol-lowering pill, had one-sixth fewer heart attacks, strokes or operations to unblock their arteries than patients taking a placebo, according to the results of a study presented on Saturday.", "print_section": "A", "print_page": "25", "source": "The New York Times", "multimedia": [], "headline": {"main": "Study Suggests a Cholesterol Pill Benefits Patients With Kidney Disease", "kicker": null, "content_kicker": null, "print_headline": "Study Suggests a Cholesterol Pill Benefits Patients With Kidney Disease", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 2, "major": "N"}, {"name": "subject", "value": "Vytorin (Drug)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Kidneys", "rank": 4, "major": "N"}], "pub_date": "2010-11-20T20:13:41+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "subsection_name": "Research", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/cb62287c-ffd9-5956-a6f3-6c8302ac0656", "word_count": 535, "uri": "nyt://article/cb62287c-ffd9-5956-a6f3-6c8302ac0656"}]